A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Josef Stehlik, MD
University of Utah
Study Chair - Michael Olymbios, MD
Natera, Inc.
Study Director - Palak Shah, MD
Inova Schar Heart and Vascular
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- University of California, San Diego
San Diego, California, United States
- University of Colorado
Aurora, Colorado, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Adventhealth Orlando
Orlando, Florida, United States
- Kansas University Medical Center
Kansas City, Kansas, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan
Ann Arbor, Michigan, United States
- Nyu Langone Health
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- University of Texas, Southwestern Medical Center
Dallas, Texas, United States
- Baylor Scott White - Temple
Temple, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- Inova Schar Heart and Vascular Institute
Falls Church, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 10 Jun 2024
- Primary completion
- 28 Feb 2027
- Completion
- 28 Feb 2027
- Last update posted
- 27 Feb 2026
- Registered enrollment
- 250
- Registry id
- NCT06414603
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.